Factors that regulate baseline and IFNγ-induced MHC-I expression on tumor cells are consistently identified on high-throughput assays (such as in vitro and in vivo CRISPR screens) as important mediators of tumor sensitivity to immune-mediated killing, while loss of these factors mediates immunotherapy resistance [65,103,202,203,204]. This evidence concerns the gene IFNG and neoplasm.